A Trial to Evaluate Safety and Efficacy of Elamipretide Primary Mitochondrial Myopathy Followed by Open-Label Extension
Clinical trial NCT03323749 · TERMINATED
Trial details
- NCT number
- NCT03323749
- Sponsor
- Stealth BioTherapeutics Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-09
- Primary completion
- 2020-02-10
- Enrollment
- 218
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.